Table 1 Cardiovascular assessments during the first year on ART

CD4 T-cells/μl

63 (2–199)

181 (7–601)^b

202 (6–516)^b

285 (44–763)^b

–

HIV RNA^a

5.14 (2.91–6.68)

1.89 (0–5.23)^b

0 (0–5.33)^b

0 (0–6.32)^b

–

BMI (kg/m²)

19.6 (13.2–36.9)

20.5 (14.7–39.8)

21.7 (16.0–40.1)^b

23.0 (13.4–40.2)^b

18.5–25^d

BP (Systolic)

110 (100–150)

110 (100–130)

110 (110–160)

120(100–146)^b

90–120^d

BP (Diastolic)

80(70–100)

80 (60–90)

80 (60–100)

80(60–90)

60–90^d

EF (%)

68 (51–84)^c

69 (50–83)

70 (61–80)

70 (50–79)^b

71 (53–77)

E/A Ratio

1.3 (0.6–4.7)^c

1.3 (0.8–1.9)

1.3 (0.8–1.9)

1.3 (1.1–1.8)

1.4 (1.0–1.9)

LVMI

94 (30–177)

99 (52–187)

100 (57–217)^c

102 (47–222)^c

83 (48–125)

cIMT (right, mm)

0.58 (0.39–0.64)

0.58(0.38–0.77)

0.57(0.45–0.90)

0.70(0.46–1.0)^b

0.58 (0.39–0.83)

cIMT (left, mm)

0.57 (0.32–0.89)

0.57(0.39–0.77)

0.51(0.32–0.89)

0.65(0.45–0.96)^b

0.58 (0.45–0.70)

Diameter (right)^e

6.4 (4.0–7.9)

6.2 (4.3–9)

5.9 (4.7–8.3)

6.2 (5.1–8.8)

(5–7.5)^d

Diameter (left)^e

6.1 (3.5–8.1)

6.2 (4.1–7.5)

6.0 (4.5–8.0)

5.8 (4.1–8.0)

(5–7.5)^d